116 related articles for article (PubMed ID: 1280891)
21. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
Milich DR; Chisari FV
J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus (HBV)-specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg).
Ducos J; Bianchi-Mondain AM; Pageaux G; Conge AM; Poncet R; Vendrell JP; Segondy M; Serre A
Clin Exp Immunol; 1996 Jan; 103(1):15-8. PubMed ID: 8565275
[TBL] [Abstract][Full Text] [Related]
23. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
J Immunol; 1995 Apr; 154(7):3162-72. PubMed ID: 7534789
[TBL] [Abstract][Full Text] [Related]
24. Overcoming class II-linked non-responsiveness to hepatitis B vaccine.
Hervás-Stubbs S; Berasain C; Golvano JJ; Lasarte JJ; Prieto I; Sarobe P; Prieto J; Borrás-Cuesta F
Vaccine; 1994 Aug; 12(10):867-71. PubMed ID: 7526566
[TBL] [Abstract][Full Text] [Related]
25. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Xie Y; Sun HX; Li D
Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
[TBL] [Abstract][Full Text] [Related]
26. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
27. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
Milich DR; Leroux-Roels GG; Louie RE; Chisari FV
J Exp Med; 1984 Jan; 159(1):41-56. PubMed ID: 6198427
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B.
Clark JR; Bartley K; Jepson CD; Craik V; March JB
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):197-204. PubMed ID: 21204995
[TBL] [Abstract][Full Text] [Related]
29. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Siegrist CA; Davis HL
FEMS Immunol Med Microbiol; 2001 Apr; 30(3):241-7. PubMed ID: 11335145
[TBL] [Abstract][Full Text] [Related]
30. Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides.
Brown SE; Howard CR; Zuckerman AJ; Steward MW
Lancet; 1984 Jul; 2(8396):184-7. PubMed ID: 6146750
[TBL] [Abstract][Full Text] [Related]
31. Identification of T cell epitopes on hepatitis B surface antigen.
Vento S
Ann Ist Super Sanita; 1991; 27(1):37-40. PubMed ID: 1720295
[TBL] [Abstract][Full Text] [Related]
32. Hemokinin-1 as an adjuvant molecule enhancing humoral and memory responses to HBsAg DNA vaccination.
Chen X; Zhang W; Gao W; Zou Q; Feng C; Liu H; Zhou C; Zhang Y; Wang B
Viral Immunol; 2012 Aug; 25(4):289-96. PubMed ID: 22876773
[TBL] [Abstract][Full Text] [Related]
33. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
34. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.
Milich DR; McLachlan A; Chisari FV; Kent SB; Thorton GB
J Immunol; 1986 Jul; 137(1):315-22. PubMed ID: 2423607
[TBL] [Abstract][Full Text] [Related]
35. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium.
Woo PC; Wong LP; Zheng BJ; Yuen KY
Vaccine; 2001 Apr; 19(20-22):2945-54. PubMed ID: 11282206
[TBL] [Abstract][Full Text] [Related]
36. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). III. Circumvention of nonresponsiveness in mice bearing HBsAg nonresponder haplotypes.
Milich DR; Alexander H; Chisari FV
J Immunol; 1983 Mar; 130(3):1401-7. PubMed ID: 6185582
[No Abstract] [Full Text] [Related]
37. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of viral hepatitis B antibody (Anti-HBs) response to a synthetic cyclic peptide by priming with anti-idiotype antibodies.
Kennedy RC; Sparrow JT; Sanchez Y; Melnick JL; Dreesman GR
Virology; 1984 Jul; 136(1):247-52. PubMed ID: 6610985
[TBL] [Abstract][Full Text] [Related]
39. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.
Desombere I; Gijbels Y; Verwulgen A; Leroux-Roels G
Clin Exp Immunol; 2000 Dec; 122(3):390-9. PubMed ID: 11122245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
